Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to standard options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of with Toripalimab and radiotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I need to provide any tissue samples, and how will they be used in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition changes during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer clinical trial (NCT06065813). Contact the study team or your healthcare provider for specific answers.

What this study is about